JIC secures SGD Pharma shareholding

Published 8th November, 2016 by Greg Morris

SGD Pharma has confirmed China Jianyin Investment Ltd (JIC) is now the group’s new shareholder.

JIC is a long-term investor with $57 billion under management. It will allow France’s SGD Pharma to focus on its development and investment plans as part of its global growth strategy.

The new shareholder, whose investment portfolio covers various businesses and geographical zones including Europe, Asia and Australia, strongly supports SGD Pharma’s management in its industrial and strategic plans.

Greg Morris

Glass International Editor

Greg Morris has been editor of Glass International and organiser of the Glassman conferences since 2012, specialising in glass packaging. Prior to this he spent five years working in newspaper journalism.